Isolation of human antibodies to tumor-associated endothelial cell markers by in vitro human endothelial cell selection with phage display libraries

Journal of Immunological Methods

Volumn 287, Issue 1-2, 2004, Pages 31-47

  Mutuberria, Ricardo ^a   Satijn, Sietske ^a   Huijbers, Angelique ^a   Van Der Linden, Edith ^a   Lichtenbeld, Hera ^a   Chames, Patrick ^a,c   Arends, Jan Willem ^a,d   Hoogenboom, Hennie R ^a,b,e  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Cellectis SA ^*  (Netherlands)

^c Arvid Wallgrens Backe 20   (France)

^d DEVENTER HOSPITAL   (Netherlands)

^e Merus Biopharmaceuticals   (Netherlands)

Author keywords

Angiogenesis markers; CDR; Cell selections; Complementarity determining region; EC; Endothelial cells; Human antibodies; Human umbilical vein endothelial cells; HUVEC; PBL; Peripheral blood leucocytes; Phage display; TEM; Tumor vasculature

Indexed keywords

ANTIBODY; CELL MARKER;

ANGIOGENESIS; ANTIBODY ISOLATION; ANTIGEN BINDING; ARTICLE; BLADDER CARCINOMA; BREAST CARCINOMA; CARCINOMA CELL; CELL LYSATE; CELL PROLIFERATION; CELL SELECTION; CELL STIMULATION; CONTROLLED STUDY; ENDOMETRIUM; ENDOTHELIUM CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; LIVER CARCINOMA; LUNG CARCINOMA; MOLECULAR WEIGHT; OVARY CARCINOMA; PHAGE DISPLAY; PLACENTA; PRIORITY JOURNAL; TUMOR VASCULARIZATION; UMBILICAL VEIN; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTIBODIES; ANTIGENS, NEOPLASM; CLONING, MOLECULAR; DNA FINGERPRINTING; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOHISTOCHEMISTRY; MOLECULAR SEQUENCE DATA; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE LIBRARY; POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; UMBILICAL VEINS;

EID: 1942424256     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.01.011     Document Type: Article

References (48)

1. Arap W., Kolonin M.G., Trepel M., Lahdenranta J., Cardo-Vila M., Giordano R.J., Mintz P.J., Ardelt P.U., Yao V.J., Vidal C.I., Chen L., Flamm A., Valtanen H., Weavind L.M., Hicks M.E., Pollock R.E., Botz G.H., Bucana C.D., Koivunen E., Cahill D., Troncoso P., Baggerly K.A., Pentz R.D., Do K.A., Logothetis C.J., Pasqualini R. Steps toward mapping the human vasculature by phage display. Nat. Med. 8:2002;121.
2. Ausubel F.M. Current protocols in molecular biology. Frederick R.B., Ausubel M., Kingston R.E., Moore D.D., Seidman J.G., Smith J.A., Struhl K., Albright L.M., Coen D.M., Varki A. Current Protocols in Molecular Biology. 1995;10.11.1 Willey, Amsterdam.
3. Birchler M., Viti F., Zardi L., Spiess B., Neri D. Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment. Nat. Biotechnol. 17:1999;984.
4. Carson-Walter E.B., Watkins D.N., Nanda A., Vogelstein B., Kinzler K.W., St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res. 61:2001;6649.
5. de Haard H.J., van Neer N., Reurs A., Hufton S.E., Roovers R.C., Henderikx P., de Bruine A.P., Arends J.W., Hoogenboom H.R. A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies. J. Biol. Chem. 274:1999;18218.
6. De Kruif J., Terstappen L., Boel E., Logtenberg T. Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library. Proc. Natl. Acad. Sci. U. S. A. 92:1995;3938.
7. Dye J.F., Jablenska R., Donnelly J.L., Lawrence L., Leach L., Clark P., Firth J.A. Phenotype of the endothelium in the human term placenta. Placenta. 22:2001;32.
8. Eberhard A., Kahlert S., Goede V., Hemmerlein B., Plate K.H., Augustin H.G. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res. 60:2000;1388.
9. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1:1995;27.
10. Gasparini G., Brooks P.C., Biganzoli E., Vermeulen P.B., Bonoldi E., Dirix L.Y., Ranieri G., Miceli R., Cheresh D.A. Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer. Clin. Cancer Res. 4:1998;2625.
11. Giordano R.J., Cardo-Vila M., Lahdenranta J., Pasqualini R., Arap W. Biopanning and rapid analysis of selective interactive ligands. Nat. Med. 7:2001;1249.
12. Giovannoni L., Viti F., Zardi L., Neri D. Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screening. Nucleic Acids Res. 29:2001;E27.
13. Grant D.S., Tashiro K., Segui-Real B., Yamada Y., Martin G.R., Kleinman H.K. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell. 58:1989;933.
14. Griffioen A.W., Molema G. Angiogenesis: potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation. Pharmacol. Rev. 52:2000;237.
15. Griffioen A.W., Coenen M.J., Damen C.A., Hellwig S.M., van Weering D.H., Vooys W., Blijham G.H., Groenewegen G. CD44 is involved in tumor angiogenesis; an activation antigen on human endothelial cells. Blood. 90:1997;1150.
16. Groenewegen G., de Ley M., Jeunhomme G.M., Buurman W.A. Supernatants of human leukocytes contain mediator, different from interferon gamma, which induces expression of MHC class II antigens. J. Exp. Med. 164:1986;131.
17. Henriksen R., Gobl A., Wilander E., Oberg K., Miyazono K., Funa K. Expression and prognostic significance of TGF-beta isotypes, latent TGF-beta 1 binding protein, TGF-beta type I and type II receptors, and endoglin in normal ovary and ovarian neoplasms. Lab. Invest. 73:1995;213.
18. Hoogenboom H.R., de Bruine A.P., Hufton S.E., Hoet R.M., Arends J.W., Roovers R.C. Antibody phage display technology and its applications. Immunotechnology. 4:1998;1.
19. Hoogenboom H.R., Lutgerink J.T., Pelsers M.M., Rousch M.J., Coote J., Van Neer N., De Bruine A., Van Nieuwenhoven F.A., Glatz J.F., Arends J.W. Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library. Eur. J. Biochem. 260:1999;774.
20. Huang X., Molema G., King S., Watkins L., Edgington T.S., Thorpe P.E. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Science. 275:1997;547.
21. Jindal S.K., Ishii E., Letarte M., Vera S., Teerds K.J., Dorrington J.H. Regulation of transforming growth factor alpha gene expression in an ovarian surface epithelial cell line derived from a human carcinoma. Biol. Reprod. 52:1995;1027.
22. Johns M., George A.J., Ritter M.A. In vivo selection of sFv from phage display libraries. J. Immunol. Methods. 239:2000;137.
23. Kim H.R., Yu J., Ustach C. Platelet-derived growth factor signaling and human cancer. J. Biochem. Mol. Biol. 36:2003;49.
24. Kumar S., Ghellal A., Li C., Byrne G., Haboubi N., Wang J.M., Bundred N. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res. 59:1999;856.
25. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680.
26. Marks J.D., Hoogenboom H.R., Bonnert T.P., McCafferty J., Griffiths A.D., Winter G. By-passing immunization: human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222:1991;581.
27. Miller D.W., Graulich W., Karges B., Stahl S., Ernst M., Ramaswamy A., Sedlacek H.H., Muller R., Adamkiewicz J. Elevated expression of endoglin, a component of the TGF-beta-receptor complex, correlates with proliferation of tumor endothelial cells. Int. J. Cancer. 81:1999;568.
28. Mutuberria R., Hoogenboom H.R., van der Linden E., de Bruine A.P., Roovers R.C. Model systems to study the parameters determining the success of phage antibody selections on complex antigens. J. Immunol. Methods. 231:1999;65.
29. Neri D., Carnemolla B., Nissim A., Leprini A., Querze G., Balza E., Pini A., Tarli L., Halin C., Neri P., Zardi L., Winter G. Targeting by affinity-matured recombinant antibody fragments of an angiogenesis associated fibronectin isoform. Nat. Biotechnol. 15:1997;1271.
30. Pasqualini R. Vascular targeting with phage peptide libraries. Q. J. Nucl. Med. 43:1999;159.
31. Pasqualini R., Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature. 380:1996;364.
32. Pelsers M.M., Lutgerink J.T., Nieuwenhoven F.A., Tandon N.N., van der Vusse G.J., Arends J.W., Hoogenboom H.R., Glatz J.F. A sensitive immunoassay for rat fatty acid translocase (CD36) using phage antibodies selected on cell transfectants: abundant presence of fatty acid translocase/CD36 in cardiac and red skeletal muscle and up-regulation in diabetes. Biochem. J. 337:1999;407.
33. Piascik P. New antibody approved for treatment of rheumatoid arthritis. J. Am. Pharm. Assoc. 43:2003;327.
34. Rajotte D., Arap W., Hagedorn M., Koivunen E., Pasqualini R., Ruoslahti E. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J. Clin. Invest. 102:1998;430.
35. Ribatti D., Nico B., Vacca A., Roncali L., Dammacco F. Endothelial cell heterogeneity and organ specificity. J. Hematother. Stem Cell Res. 11:2002;81.
36. Ridgway J.B., Ng E., Kern J.A., Lee J., Brush J., Goddard A., Carter P. Identification of a human anti-CD55 single-chain Fv by subtractive panning of a phage library using tumor and nontumor cell lines. Cancer Res. 59:1999;2718.
37. Roovers R.C., van der Linden E., de Bruine A.P., Arends J.W., Hoogenboom H.R. Identification of colon tumour-associated antigens by phage antibody selections on primary colorectal carcinoma. Eur. J. Cancer. 37:2001;542.
38. Roovers R.C., van der Linden E., de Bruine A.P., Arends J.W., Hoogenboom H.R. In vitro characterisation of a monovalent and bivalent form of a fully human anti Ep-CAM phage antibody. Cancer Immunol. Immunother. 50:2001;51.
39. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning - A Laboratory Manual. 1990;Cold Spring Harbor Laboratory, New York.
40. Soker S., Gollamudi-Payne S., Fidder H., Charmahelli H., Klagsbrun M. Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165. J. Biol. Chem. 272:1997;31582.
41. St Croix B., Rago C., Velculescu V., Traverso G., Romans K.E., Montgomery E., Lal A., Riggins G.J., Lengauer C., Vogelstein B., Kinzler K.W. Genes expressed in human tumor endothelium. Science. 289:2000;1197.
42. Vermeulen P.B., Verhoeven D., Hubens G., Van Marck E., Goovaerts G., Huyghe M., De Bruijn E.A., Van Oosterom A.T., Dirix L.Y. Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas. Ann. Oncol. 6:1995;59.
43. Viti F., Giovannoni L., Neri D. Recombinant antibodies for the selective targeting of tumor neovasculature. Curr. Opin. Drug Discov. Dev. 5:2002;204.
44. Wang J.M., Kumar S., Pye D., van Agthoven A.J., Krupinski J., Hunter R.D. A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int J. Cancer. 54:1993;363.
45. Wei Y.Q., Wang Q.R., Zhao X., Yang L., Tian L., Lu Y., Kang B., Lu C.J., Huang M.J., Lou Y.Y., Xiao F., He Q.M., Shu J.M., Xie X.J., Mao Y.Q., Lei S., Luo F., Zhou L.Q., Liu C.E., Zhou H., Jiang Y., Peng F., Yuan L.P., Li Q., Wu Y., Liu J.Y. Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine. Nat. Med. 6:2000;1160.
46. Willam C., Koehne P., Jurgensen J.S., Grafe M., Wagner K.D., Bachmann S., Frei U., Eckardt K.U. Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cells. Circ. Res. 87:2000;370.
47. Winter G., Griffiths A.D., Hawkins R.E., Hoogenboom H.R. Making antibody by phage display technology. Annu. Rev. Immunol. 12:1994;433.
48. Yeh C.H., Peng H.C., Huang T.F. Cytokines modulate integrin alpha(v)beta(3)-mediated human endothelial cell adhesion and calcium signaling. Exp. Cell Res. 251:1999;57.